• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-140-5p对肝癌阿霉素耐药性的抑制作用

Inhibitory effect of miR-140-5p on doxorubicin resistance of hepatocellular carcinoma.

作者信息

Gao Xiaojie, Jiang Yan, Li Yingying

机构信息

Department of Pharmacy, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou Zhejiang 310005, P.R. China.

Department of Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.

出版信息

Exp Ther Med. 2021 May;21(5):507. doi: 10.3892/etm.2021.9938. Epub 2021 Mar 18.

DOI:10.3892/etm.2021.9938
PMID:33791016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8005744/
Abstract

To investigate the role of microRNA (miR)-140-5p in doxorubicin (DOX) sensitivity in hepatocellular carcinoma, miR-140-5p and peptidyl-prolyl isomerase NIMA-interacting 1 (PIN1) expression was first evaluated in hepatocellular carcinoma tissues using starBase. Next, experiments were performed. Cell line expression of miR-140-5p and PIN1 expression was detected by reverse transcription polymerase chain reaction. Cell viability and proliferation were determined by the Cell Counting Kit-8 and EdU assays. The relationship between miR-140-5p and PIN1 was evaluated by TargetScan and a luciferase reporter system. Western blotting was used to detect the expression of PIN1. It was observed that miR-140-5p was downregulated in hepatocellular carcinoma tissues and cell lines compared with normal samples in HCC or normal liver cells. Gain-of-function experiments revealed that miR-140-5p mimics were able to enhance DOX sensitivity of hepatocellular carcinoma cells. Further studies revealed that PIN1 was a target gene of miR-140-5p. Suppression of PIN1 led to higher DOX sensitivity in hepatocellular carcinoma cells. Finally, when comparing a PIN1-siRNA alone group and a PIN1-siRNA plus miR-140-5p inhibitor group, there was no significant difference in cell viability. Furthermore, miR-140-5p mimics did not reduce the sensitivity of PIN1mut plasmid to DOX in HUH7 and SNU449 cells. The present study demonstrated that miR-140-5p could enhance DOX sensitivity in hepatocellular carcinoma cells by targeting PIN1.

摘要

为研究微小RNA(miR)-140-5p在肝细胞癌对多柔比星(DOX)敏感性中的作用,首先使用starBase评估肝细胞癌组织中miR-140-5p和肽基脯氨酰异构酶NIMA相互作用蛋白1(PIN1)的表达。接下来,进行实验。通过逆转录聚合酶链反应检测细胞系中miR-140-5p和PIN1的表达。采用细胞计数试剂盒-8和EdU检测法测定细胞活力和增殖情况。通过TargetScan和荧光素酶报告系统评估miR-140-5p与PIN1之间的关系。采用蛋白质免疫印迹法检测PIN1的表达。结果观察到,与肝癌或正常肝细胞中的正常样本相比,miR-140-5p在肝细胞癌组织和细胞系中表达下调。功能获得实验表明,miR-140-5p模拟物能够增强肝癌细胞对DOX的敏感性。进一步研究表明,PIN1是miR-140-5p的靶基因。抑制PIN1可使肝癌细胞对DOX的敏感性更高。最后,比较单独使用PIN1-siRNA组和PIN1-siRNA加miR-140-5p抑制剂组时,细胞活力无显著差异。此外,miR-140-5p模拟物并未降低HUH7和SNU449细胞中PIN1mut质粒对DOX的敏感性。本研究表明,miR-140-5p可通过靶向PIN1增强肝癌细胞对DOX的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/30b977c7b514/etm-21-05-09938-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/0f1dd5a00ca8/etm-21-05-09938-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/7c2e9d155942/etm-21-05-09938-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/735694491cf6/etm-21-05-09938-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/86c79cb9e52a/etm-21-05-09938-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/30b977c7b514/etm-21-05-09938-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/0f1dd5a00ca8/etm-21-05-09938-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/7c2e9d155942/etm-21-05-09938-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/735694491cf6/etm-21-05-09938-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/86c79cb9e52a/etm-21-05-09938-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc35/8005744/30b977c7b514/etm-21-05-09938-g04.jpg

相似文献

1
Inhibitory effect of miR-140-5p on doxorubicin resistance of hepatocellular carcinoma.miR-140-5p对肝癌阿霉素耐药性的抑制作用
Exp Ther Med. 2021 May;21(5):507. doi: 10.3892/etm.2021.9938. Epub 2021 Mar 18.
2
MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis/trans isomerase.MicroRNA-150-5p 通过调控脯氨酰顺反异构酶抑制人喉表皮样癌细胞的增殖和侵袭。
Braz J Otorhinolaryngol. 2023 May-Jun;89(3):383-392. doi: 10.1016/j.bjorl.2023.03.003. Epub 2023 Mar 13.
3
MiR-26a-5p Inhibits Cell Proliferation and Enhances Doxorubicin Sensitivity in HCC Cells via Targeting AURKA.miR-26a-5p 通过靶向 AURKA 抑制 HCC 细胞增殖并增强阿霉素敏感性。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819851833. doi: 10.1177/1533033819851833.
4
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.微小 RNA-140-5p 通过直接靶向独特的异构酶 Pin1 来抑制肝癌,从而阻断多种致癌途径。
Sci Rep. 2017 Apr 6;7:45915. doi: 10.1038/srep45915.
5
miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.miR-874-3p在肝细胞癌中表达下调,并对PIN1表达起负向调控作用。
Oncotarget. 2017 Feb 14;8(7):11343-11355. doi: 10.18632/oncotarget.14526.
6
MicroRNA-361-5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9.微小RNA-361-5p通过靶向丝裂原活化蛋白激酶激酶激酶9诱导肝癌细胞凋亡并增强药物敏感性。
Exp Ther Med. 2021 Jun;21(6):574. doi: 10.3892/etm.2021.10006. Epub 2021 Mar 31.
7
MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.微小RNA-296-5p(miR-296-5p)通过直接靶向肽基脯氨酰顺反异构酶NIMA相互作用蛋白1(Pin1)在前列腺癌中发挥肿瘤抑制作用。
Biochim Biophys Acta. 2014 Sep;1843(9):2055-66. doi: 10.1016/j.bbamcr.2014.06.001. Epub 2014 Jun 8.
8
miRNA-125a-5p inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting TP53 regulated inhibitor of apoptosis 1 and Bcl-2-like-2 protein.微小RNA-125a-5p通过靶向TP53调控的凋亡抑制因子1和Bcl-2样蛋白2抑制肝癌细胞增殖并诱导凋亡。
Exp Ther Med. 2019 Aug;18(2):1196-1202. doi: 10.3892/etm.2019.7674. Epub 2019 Jun 14.
9
microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.miRNA-485-5p 通过阻断 WBP2/Wnt 信号通路抑制肝癌的进展。
Cell Signal. 2020 Feb;66:109466. doi: 10.1016/j.cellsig.2019.109466. Epub 2019 Nov 6.
10
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.微小RNA-155-5p通过PI3K/Akt信号通路抑制PTEN从而促进肝细胞癌进展。
Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19.

引用本文的文献

1
CircRNA-NOLC1 mediates Insulin-like growth factor 1 receptor via performing as a ceRNA of miRNA-140-5p to facilitate testicular germ cell tumor advancement.环状RNA-NOLC1通过作为miRNA-140-5p的竞争性内源RNA来介导胰岛素样生长因子1受体,以促进睾丸生殖细胞肿瘤进展。
Clinics (Sao Paulo). 2025 May 13;80:100629. doi: 10.1016/j.clinsp.2025.100629. eCollection 2025.
2
The mechanisms of Pin1 as targets for cancer therapy.Pin1作为癌症治疗靶点的作用机制。
Front Immunol. 2024 Nov 18;15:1482088. doi: 10.3389/fimmu.2024.1482088. eCollection 2024.
3
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities.

本文引用的文献

1
MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.MicroRNA-1251-5p 通过靶向 AKAP12 促进肝癌的肿瘤生长和转移。
Biomed Pharmacother. 2020 Feb;122:109754. doi: 10.1016/j.biopha.2019.109754. Epub 2019 Dec 30.
2
MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin.微小 RNA-509-3p 抑制骨肉瘤细胞迁移、侵袭和增殖,并增加骨肉瘤对顺铂的敏感性。
Sci Rep. 2019 Dec 13;9(1):19089. doi: 10.1038/s41598-019-55170-2.
3
Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
微小 RNA 与肝细胞癌发病机制:对机制和治疗机会的深入了解。
Int J Mol Sci. 2024 Aug 29;25(17):9393. doi: 10.3390/ijms25179393.
4
miRNAs as short non-coding RNAs in regulating doxorubicin resistance.微小RNA作为短链非编码RNA在调节阿霉素耐药性中的作用
J Cell Commun Signal. 2023 Dec;17(4):1181-1202. doi: 10.1007/s12079-023-00789-0. Epub 2023 Nov 29.
5
The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.EMT相关非编码RNA调控轴在肝细胞癌中的关键作用。
Front Pharmacol. 2023 Sep 11;14:1270425. doi: 10.3389/fphar.2023.1270425. eCollection 2023.
沉默长链非编码RNA FOXD2-AS1可抑制耐药胶质瘤细胞的增殖、迁移、侵袭及耐药性,并通过微小RNA-98-5p/CPEB4轴促进其凋亡。
Aging (Albany NY). 2019 Nov 26;11(22):10266-10283. doi: 10.18632/aging.102455.
4
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.FOXC1对miR-31-5p的调控通过靶向LATS2赋予结直肠癌对奥沙利铂的抗性。
Cancers (Basel). 2019 Oct 16;11(10):1576. doi: 10.3390/cancers11101576.
5
High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients.微小RNA-196a的高表达与年轻患者肝细胞癌的进展相关。
Cancers (Basel). 2019 Oct 13;11(10):1549. doi: 10.3390/cancers11101549.
6
Knockdown of interferon-stimulated gene 15 affects the sensitivity of hepatocellular carcinoma cells to norcantharidin.干扰素刺激基因15的敲低影响肝癌细胞对去甲斑蝥素的敏感性。
Exp Ther Med. 2019 Nov;18(5):3751-3758. doi: 10.3892/etm.2019.8028. Epub 2019 Sep 19.
7
MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents.miR-3163 靶向 ADAM-17,增强肝癌细胞对分子靶向药物的敏感性。
Cell Death Dis. 2019 Oct 14;10(10):784. doi: 10.1038/s41419-019-2023-1.
8
miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.miR-205-5p下调通过上调ERp29降低乳腺癌细胞对吉西他滨的敏感性。
Exp Ther Med. 2019 Nov;18(5):3525-3533. doi: 10.3892/etm.2019.7962. Epub 2019 Aug 30.
9
MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4.微小RNA-608通过抑制TFAP4促进多柔比星处理的非小细胞肺癌细胞凋亡。
Front Genet. 2019 Sep 10;10:809. doi: 10.3389/fgene.2019.00809. eCollection 2019.
10
miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4.miR-182 通过靶向 PDCD4 促进多发性骨髓瘤中的细胞黏附介导的耐药性。
Pathol Res Pract. 2019 Nov;215(11):152603. doi: 10.1016/j.prp.2019.152603. Epub 2019 Aug 17.